Journal of Pharmacogenomics & Pharmacoproteomics

miRNA genetic variants: As potential diagnostic biomarkers for oral cancer

What is the Logic behind Treating Some Heart Failure Patients without ACE Inhibitors and Beta-Blockers?

Personalized Medicine for Severe Asthma: How Far Have We Achieved?

Looking through Philippine’s K to 12 Curriculum in Mathematics and Science vis-a-vis TIMSS 2015 Assessment Framework

CYP2C9 Polymorphism and Use of Oral Nonsteroidal Anti-Inflammatory Drugs

Oral anticoagulation: a changing practice

 Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases

Synonymous Variant of ACE Gene (rs4343) is Coupled with Early Age at Onset and Diminished Diabetic Duration in South Indian Diabetic Nephropathy Patients

Diabetes in India: what is different?

ACE insertion/deletion polymorphism and diabetic nephropathy: clinical implications of genetic information

Computational dynamic approaches for temporal omics data with applications to systems medicine

Chemical named entities recognition: a review on approaches and applications

Natural killer cells in patients with hematologic malignancies, solid tumors and in recipients of hematopoietic stem cell transplantation

Epigenetics in myelodysplastic syndromes

Genetic and epigenetic strategies for advancing ovarian cancer immunotherapy

REVIEW ON PRAKRITI (HUMAN CONSTITUTION) IN THE VIEW POINT OF PHARMACOGENOMICS

Research & Reviews: Journal of Pharmacology and Toxicological Studies

Specificity of transaminase activities in the prediction of drug-induced hepatotoxicity

Estimation of potential risk of allyl alcohol induced liver injury in diabetic patients using type 2 diabetes spontaneously diabetic Torii-Leprfa (SDT fatty) rats

Network Analytics for the miRNA Regulome and miRNA-Disease Interactions